Endocyte to Begin Trial of Prostate Cancer Treatment
West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is moving forward with its recently-acquired late-stage prostate cancer therapy. The company says it will soon begin a phase 3 trial for PSMA-617, ...... Read More
